AKT1 and glioma: However, when administrated with exogenous RECK followed by the addition of the inhibitor LY294002, glioma cells displayed unchanged total protein expression of AKT and obviously down-regulated extent of AKT phosphorylation and PI3K-p85 in comparison with the cells added with the exogenous RECK alone (Figure 7B).